The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Stephanie Lira discussing scaling operations in theranostics clinical research. There has been tremendous ...
The 2026 PSMA & Beyond conference featured a session on challenges of radioligand therapy and a presentation by Dr. Michael Hofman discussing the expansion of the theranostic dream. Only 8 years ago, ...
THE WOODLANDS, Texas--(BUSINESS WIRE)--Fuzionaire Diagnostics, Inc. announced today that it has changed its name to Fuzionaire Theranostics, Inc. (“Fuzionaire Tx”). Originally directed to make ...
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and ...
Reston, VA—A newly established PSMA PET scoring system can successfully predict whether metastatic castration-resistant prostate cancer (mCRPC) patients will respond to treatment with 177 Lu-PSMA ...
CHICAGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics ...
SYDNEY, Feb. 16, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results